Publications by authors named "Lise Alter"

Claim this Profile
R
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health.
Antoine Vanier, Judith Fernandez, Sophie Kelley, Lise Alter, Patrick Semenzato

BMJ Evid Based Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Christophe Roussel, Olivier Chassany, Isabelle Durand-Zaleski, Anne Josseran, Lise Alter

Therapie· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France.
Christophe Roussel, Olivier Chassany, Isabelle Durand-Zaleski, Anne Josseran, Lise Alter

Therapie· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22.
Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Juliette Paireau, Daniel Levy-Bruhl, Lise Alter

Euro Surveill· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
Cécile Tran Kiem, Alessio Andronico, Paolo Bosetti, Juliette Paireau, Lise Alter

Euro Surveill· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis